LYON HCL
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DEPLANQUE, Dominique
CoviCompare_J, NCT05037266: Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen

Terminated
4
27
Europe
COVID-19 Vaccine Janssen (Ad26.COV2-S)
Centre Hospitalier Universitaire de Saint Etienne
Healthy Volunteers
02/22
01/24
MelBase, NCT02828202: Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

Recruiting
N/A
6000
Europe
Biological, Tissular, Quality of life
Assistance Publique - Hôpitaux de Paris, National Cancer Institute (NCI)
Malignant Melanoma
03/26
03/26
COVIFERON, NCT06762002: Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort

Not yet recruiting
N/A
500
Europe
blood sample
Institut National de la Santé Et de la Recherche Médicale, France
Immunology, Allergy, Genetic Diseases, Infectious Diseases
01/29
01/29
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DEPLANQUE, Dominique
CoviCompare_J, NCT05037266: Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen

Terminated
4
27
Europe
COVID-19 Vaccine Janssen (Ad26.COV2-S)
Centre Hospitalier Universitaire de Saint Etienne
Healthy Volunteers
02/22
01/24
MelBase, NCT02828202: Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

Recruiting
N/A
6000
Europe
Biological, Tissular, Quality of life
Assistance Publique - Hôpitaux de Paris, National Cancer Institute (NCI)
Malignant Melanoma
03/26
03/26
COVIFERON, NCT06762002: Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort

Not yet recruiting
N/A
500
Europe
blood sample
Institut National de la Santé Et de la Recherche Médicale, France
Immunology, Allergy, Genetic Diseases, Infectious Diseases
01/29
01/29

Download Options